Following-up allogeneic transplantation recipients during the COVID-19 pandemic

Lancet Haematol. 2020 Aug;7(8):e564-e565. doi: 10.1016/S2352-3026(20)30176-9. Epub 2020 May 22.

Authors

Maria Teresa Lupo-Stanghellini¹, Carlo Messina², Sarah Marktel², Matteo G Carrabba², Jacopo Peccatori², Consuelo Corti², Fabio Ciceri³

Affiliations

¹ Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: lupostanghellini.mariateresa@hsr.it.
² Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

No abstract available

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections / transmission*
Coronavirus Infections / virology
Disease Management
Follow-Up Studies
Graft vs Host Disease / diagnosis*
Graft vs Host Disease / etiology
Graft vs Host Disease / therapy*
Humans
Pandemics
Pneumonia, Viral / transmission*
Pneumonia, Viral / virology
SARS-CoV-2
Stem Cell Transplantation / adverse effects*
Telemedicine / methods*
Transplantation, Homologous